We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+5.05%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$56.6B
AUM Growth
+$810M
Cap. Flow
-$1.48B
Cap. Flow %
-2.61%
Top 10 Hldgs %
13.48%
Holding
2,531
New
387
Increased
823
Reduced
1,010
Closed
163

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$94.6M
2
AMAT icon
Applied Materials
AMAT
+$91.8M
3
ANET icon
Arista Networks
ANET
+$73.5M
4
ILMN icon
Illumina
ILMN
+$50.4M
5
TV icon
Televisa
TV
+$49.9M

Sector Composition

Rank Sector Weight
1 Healthcare 15.88%
2 Financials 15.63%
3 Technology 12.66%
4 Energy 10.4%
5 Industrials 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOGL
2051
DELISTED
Golden Ocean Group
GOGL
$33K ﹤0.01%
+4,100
New +$33.2K
MRAM icon
2052
Everspin Technologies
MRAM
$354M
$33K ﹤0.01%
+4,400
New +$41.5K
SBLK icon
2053
Star Bulk Carriers
SBLK
$3.14B
$33K ﹤0.01%
+2,900
New +$30.1K
SHYF
2054
DELISTED
The Shyft Group
SHYF
$33K ﹤0.01%
2,100
+52
+3% +$790
TGI
2055
DELISTED
Triumph Group
TGI
$33K ﹤0.01%
+1,200
New +$36K
PETQ
2056
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$33K ﹤0.01%
+1,500
New +$34.6K
ASXC
2057
DELISTED
Asensus Surgical, Inc.
ASXC
$33K ﹤0.01%
+1,300
New +$40K
SUNW
2058
DELISTED
Sunworks, Inc.
SUNW
$33K ﹤0.01%
+4,424
New +$37.8K
DMK
2059
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$33K ﹤0.01%
+106
New +$34.9K
ZYNE
2060
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$33K ﹤0.01%
+2,600
New +$29.8K
ACGN
2061
DELISTED
Aceragen Inc
ACGN
$33K ﹤0.01%
+115
New +$32.8K
DSPG
2062
DELISTED
DSP Group Inc
DSPG
$33K ﹤0.01%
+2,606
New +$34.3K
PMBC
2063
DELISTED
Pacific Mercantile Bancorp
PMBC
$33K ﹤0.01%
+3,726
New +$34.3K
ACIA
2064
DELISTED
Acacia Communications Inc
ACIA
$33K ﹤0.01%
+900
New +$36.7K
IOTS
2065
DELISTED
Adesto Technologies Corp
IOTS
$33K ﹤0.01%
+5,105
New +$38.7K
OPB
2066
DELISTED
Opus Bank Common Stock
OPB
$33K ﹤0.01%
+1,200
New +$31.1K
JCP
2067
DELISTED
J.C. Penney Company, Inc.
JCP
$33K ﹤0.01%
10,400
-18,800
-64% -$60.5K
MB
2068
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
$33K ﹤0.01%
+1,100
New +$33.9K
BIOA
2069
DELISTED
BioAmber Inc.
BIOA
$33K ﹤0.01%
+81,983
New +$39K
BDSI
2070
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$33K ﹤0.01%
+11,200
New +$31K
AFAM
2071
DELISTED
Almost Family Inc
AFAM
$33K ﹤0.01%
+600
New +$31.9K
APPS icon
2072
Digital Turbine
APPS
$1.02B
$32K ﹤0.01%
+18,000
New +$29.6K
DHT icon
2073
DHT Holdings
DHT
$2.97B
$32K ﹤0.01%
+8,900
New +$34.5K
ENVA icon
2074
Enova International
ENVA
$5.9B
$32K ﹤0.01%
+2,100
New +$30.8K
EPM icon
2075
Evolution Petroleum
EPM
$137M
$32K ﹤0.01%
+4,700
New +$33K

Similar funds

Macquarie Group's Q4 2017 Portfolio in Review

As of Q4 2017, Macquarie Group held 2,531 positions worth $56.6B, up 1.5% from $55.7B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Macquarie Group's Q4 2017 filing shows 387 new, 823 increased, 1,010 reduced and 163 closed positions. Its largest new stake was WPP: 343,817 shares worth $31.1M. The largest sale was Marathon Oil Corporation, an estimated $149M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Financials and Technology.

  • Macquarie Group's largest Q4 2017 buy was WPP: 343,817 shares worth $31.1M.
  • Macquarie Group added most to CME Group in Q4 2017, an estimated $94.6M increase.
  • Macquarie Group's biggest Q4 2017 reduction was Marathon Oil Corporation, cutting an estimated $149M.
  • Macquarie Group fully exited Alexander & Baldwin in Q4 2017, selling an estimated $30.1M.
  • Macquarie Group's ten largest holdings make up 13% of its $56.6B portfolio in Q4 2017.
  • Macquarie Group opened 387 new positions and closed 163 in Q4 2017.
  • Macquarie Group's portfolio value rose 1.5% quarter-over-quarter to $56.6B.

Based on Macquarie Group's 13F filing for Q4 2017, filed 15 Feb 2018.